deguo wang

deguo wang

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Food Control
Verified
Journal Article
Closed access
Xiao-Hua ZhangXiao-Hua Zhang
Xiao-Hua Zhang
XQXiang-Dong Qing
Xiang-Dong Qing
SMShu-Ting Mu
Shu-Ting Mu
DWdeguo wang
deguo wang
JZJing-Jing Zheng
Jing-Jing Zheng
ZLZhi Liu
Zhi Liu

25 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
WXWen Xing
Wen Xing
CWChaoling Wen
Chaoling Wen
DWdeguo wang
deguo wang
HSHui Shao
Hui Shao
CLChunhong Liu
Chunhong Liu
Opeyemi Joshua OlatunjiOpeyemi Joshua Olatunji
Opeyemi Joshua Olatunji
Doxorubicin (DXB) is one of the most commonly used anticancer agents for treating solid and hematological malignancies; however, DXB-induced cardiorenal toxicity presents a limiting factor to its clinical usefulness in cancer patients. Costunolide (COST) is a naturally occurring sesquiterpene lactone with excellent anti-inflammatory, antioxidant and antiapoptotic properties. This study evaluated the effect of COST on DXB-induced cardiorenal toxicity in rats. Rats were orally treated with COST for 4 weeks and received weekly 5 mg/kg doses of DXB for three weeks. Cardiorenal biochemical biomarkers, lipid profile, oxidative stress, inflammatory cytokines, histological and immunohistochemical analyses were evaluated. DXB-treated rats displayed significantly increased levels of lipid profiles, markers of cardiorenal dysfunction (aspartate aminotransferase, creatine kinase, lactate dehydrogenase, troponin T, blood urea nitrogen, uric acid and creatinine). In addition, DXB markedly upregulated cardiorenal malondialdehyde, tumor necrosis factor-α, interleukin-1β, interleukin-6 levels and decreased glutathione, superoxide dismutase and catalase activities. COST treatment significantly attenuated the aforementioned alterations induced by DXB. Furthermore, histopathological and immunohistochemical analyses revealed that COST ameliorated the histopathological features and reduced p53 and myeloperoxidase expression in the treated rats. These results suggest that COST exhibits cardiorenal protective effects against DXB-induced injury presumably via suppression of oxidative stress, inflammation and apoptosis.

1 January 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YWYong Wu
Yong Wu
ZHZhengtao Hu
Zhengtao Hu
DWdeguo wang
deguo wang
KLKun Lv
Kun Lv
NHNengwei Hu
Nengwei Hu

1 June 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NSNan Sun
Nan Sun
YMYong Mei
Yong Mei
ZHZhengtao Hu
Zhengtao Hu
WXWen Xing
Wen Xing
KLKun Lv
Kun Lv
DWdeguo wang
deguo wang

27 March 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
YZYingying Zhang
Yingying Zhang
XLXueqin Li
Xueqin Li
XKXiang Kong
Xiang Kong
MZMengying Zhang
Mengying Zhang
DWdeguo wang
deguo wang
LKLv Kun
Lv Kun
Accumulating evidence indicates that regulators of macrophage polarization may exert pivotal functions in the development of coxsackievirus B3 (CVB3)‐induced viral myocarditis (VM). However, the mechanisms underlying macrophage polarization remain to be explored. Here, we sought to identify novel and functionally important long non‐coding RNAs (lncRNAs) during macrophage polarization and to investigate their function and contribution to VM. In this study, we identified the lncRNA AK085865 as an important regulator of macrophage polarization. Knock‐down of AK085865 diminished phenotypical expression of M2 macrophages while promoting polarization to the M1 phenotype. Moreover, AK085865−/− mice had increased susceptibility to CVB3‐induced VM. We observed striking bias towards M1 macrophages, whereas the M2 population was decreased in AK085865−/− VM mice. Collectively, our findings uncover a critical role of AK085865 in the regulation of macrophage polarization in vitro and in vivo, identifying a new player in the development of VM and providing a potential clinically significant therapeutic target.

7 June 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YWYong Wu
Yong Wu
HZHuabin Zhang
Huabin Zhang
YWYue Wang
Yue Wang
YZYing Zhang
Ying Zhang
ZHZongyuan Hong
Zongyuan Hong
DWdeguo wang
deguo wang
Integrated stress response (ISR) is activated to promote cell survival by maintaining the phosphorylation of eukaryotic translation initiation factor 2 (eIF2α). We investigated whether Sephin1 enhances ISR and attenuates myocardial ischemia-reperfusion (MIR) injury. Male C57BL/6 J mice were injected with Sephin1 (2 mg/kg,i.p.) 30 min before surgery to establish a model of MIR with 45 min ischemia and 180 min reperfusion. In vitro, the H9C2 cell line with hypoxia-reoxygenation (H/R) was used to simulate MIR. Myocardial injury was evaluated by echocardiography, histologic observation after staining with TTC and H&E and electron microscopy. ISR, autophagy and apoptosis in vivo and in vitro were evaluated by immunoblotting, immunohistochemistry, immunofluorescence, and flow cytometry, respectively. Global protein synthesis was determined using a non-radioactive SUnSET Assay based on the puromycin method. Autophinib, an autophagy-specific inhibitor, was used to investigate the correlation between autophagy and apoptosis in the presence of Sephin1. In vivo, Sephin1 significantly reduced myocardial injury and improved the cardiac function in MIR mice. Sephin1 administration prolonged ISR, reduced cell apoptosis, and promoted autophagy. In vitro, Sephin1 increased the number of stress granules (SGs) and autophagic vesicles, enhanced ISR and related protein synthesis suppression, and reduced cell apoptosis. Autophinib partly reversed autophagosome formation and apoptosis in H9c2 cells. Sephin1 enhances ISR and related protein synthesis suppression, ameliorates myocardial apoptosis, and promotes autophagy during MIR stress. Sephin1 could act as a noval ISR enhancer for managing acute myocardial ischemia disease.